Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Morbidity and mortality associated with electroconvulsive therapy: a retrospective cohort study

EF 2017-18

Résumé
Depression has recently become the leading cause of illness burden worldwide. It is usually treated with either medications or psychotherapy but a substantial number of people do not respond to these treatments. In this case, a treatment known as electroconvulsive therapy (ECT) may be offered. ECT uses electricity to induce a generalized seizure, which has been shown to be effective in treatment resistant depression.Despite its effectiveness, there is significant fear around the use of ECT as a large percentage of the population believes that ECT frequently causes death. However, recent work using administrative health data from Ontario found extremely low rates of adverse medical outcomes – similar to low-risk outpatient surgeries.Though we know that ECT is associated with low rates of adverse medical outcomes, we do not know the specific contribution of ECT to these rates as individuals with depression have higher rates of adverse medical outcomes. Determining the specific contribution of ECT to these adverse outcomes requires comparing a group of individuals who receive ECT to a group of similar individuals who do not receive ECT. While there have been previous studies comparing individuals receiving ECT to those not receiving ECT, these have been limited by differences between groups and have also been conducted in a single location.Therefore, the goal of this study is compare adverse medical outcomes between depressed individuals who receive ECT and a carefully matched group of depressed individuals who do not receive ECT using data from the province of Ontario. We hypothesize there will be no difference in adverse medical outcomes between the two groups, which will support the use of ECT as a safe procedure for the treatment of depression.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386398
Name
Kaster Tyler
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Morbidity and mortality associated with electroconvulsive therapy: a retrospective cohort study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Electroconvulsive Therapy; Medical Adverse Events; Mood Disorders; Mortality; Observational Cohort; Retrospective Study
Abstract
Depression has recently become the leading cause of illness burden worldwide. It is usually treated with either medications or psychotherapy but a substantial number of people do not respond to these treatments. In this case, a treatment known as electroconvulsive therapy (ECT) may be offered. ECT uses electricity to induce a generalized seizure, which has been shown to be effective in treatment resistant depression.Despite its effectiveness, there is significant fear around the use of ECT as a large percentage of the population believes that ECT frequently causes death. However, recent work using administrative health data from Ontario found extremely low rates of adverse medical outcomes – similar to low-risk outpatient surgeries.Though we know that ECT is associated with low rates of adverse medical outcomes, we do not know the specific contribution of ECT to these rates as individuals with depression have higher rates of adverse medical outcomes. Determining the specific contribution of ECT to these adverse outcomes requires comparing a group of individuals who receive ECT to a group of similar individuals who do not receive ECT. While there have been previous studies comparing individuals receiving ECT to those not receiving ECT, these have been limited by differences between groups and have also been conducted in a single location.Therefore, the goal of this study is compare adverse medical outcomes between depressed individuals who receive ECT and a carefully matched group of depressed individuals who do not receive ECT using data from the province of Ontario. We hypothesize there will be no difference in adverse medical outcomes between the two groups, which will support the use of ECT as a safe procedure for the treatment of depression.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kaster, Tyler
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~